Early Gliflozin for Elderly Patients With Acute Decompensated Heart Failure in the Emergency Department

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial is described as a feasibility study testing whether the procedures can actually be set up and run smoothly in the emergency department — does that mean there's less known yet about whether the gliflozin treatment itself will help me, compared to a more advanced trial?
2. 2Since the trial is specifically for elderly patients arriving at the emergency department with acute decompensated heart failure, would I need to be enrolled right there in the ED, and is that kind of urgent decision realistic given how unwell I might be feeling at that moment?
3. 3The trial is not yet recruiting, so if it sounds like a good fit, how long might I have to wait before it opens, and would starting standard heart failure treatment in the meantime affect whether I'd still be eligible?
4. 4One of the things being measured is how often patients refuse to participate and why — what are the main reasons doctors expect patients might say no to this study, and are any of those concerns relevant to my situation?
5. 5If I join this trial and then find the telephone follow-up calls or other protocol demands too difficult to manage, what happens to my ongoing heart failure care — would I still have access to the same treatment options I'd have outside the trial?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.